COMPANY NEWS

Semex Giving Away Two Calves Genomically Tested For Immunity At World Dairy Expo

The best giveaway at World Dairy Expo is healthier than ever! Semex is breaking ground once again by giving away two heifers that are genomically tested to be high immune responders.

“We all know that a healthier herd is a more profitable herd,” says Michael Hurst, Semex Director, US Sales & Business Development. “And this year at our tent, we’re actually giving away two high GTPI heifers that have been genomically tested to be more resistant to disease. They’re healthier than other calves and their genomics proves it. We’re the only company that has this test and the only exhibitor at World Dairy Expo that can literally give you a healthier herd…. All you need to do is come and enter!”   

Launched in early 2018, Semex’s Elevate™ program is a genomic testing program that is unique in many ways, including that it is the only test that offers an Immunity female test. This means producers no longer have to guess which cows are their healthiest. Instead, Elevate helps tailor their breeding program with both genomic information and Immunity results, making faster genetic progress towards a stronger, more disease resistant herd.

“We used Elevate for our own testing,” says Paul Krueger, VP, Global Key Account & Solutions Strategy. “The results are easy to follow, with a designation of low, medium or high for Immune Response. These heifers were high responders, meaning they’re more resistant to common diseases. Stopping by the Semex Tent at World Dairy Expo and entering to win one of these calves could be just the start of a healthier herd for you with Semex!”

Enter to win one of these calves at the Semex Tent during World Dairy Expo, join us for hospitality from 5:00-7:00 pm on Thursday and Friday nights, with a live calf draw at 6:00 pm both nights. Winners need not be present to win.
... Read More...

SEMEX INTERNATIONAL SALES & SUPPORT DEPARTMENTS GROW

Semex is pleased to announce the appointment of two individuals to key positions within the organization:


Matthew McCready has accepted the role of Director, International Sales & Business Development, effective September 10, 2018
Peter Van Beek has accepted the role of Key Account Manager, effective September 1, 2018


Reporting to Drew Sloan, Vice President, International Sales, Matthew McCready will lead Semex’s Asian business unit, providing leadership for the ongoing development of our product portfolio, including both Semex’s genetic products and solutions.

“We look forward to Matt contributing to our growth and profitability in these key markets,” says Sloan. “This market, including China, is key to Semex’s future. His passion for connecting with clients and global marketing experience make him a valuable asset to our team.”

Most recently Matt was Director of Business Development, Hybrid Turkeys at Hendrix Genetics, leading their global marketing and working closely with global sales directors and region managers. Previous to that, Matt held several positions at PepsiCo Canada. A graduate of the University of Guelph with a bachelor of commerce, agriculture business, Matt comes from an agricultural background.

Reporting to Paul Krueger, Vice President, Global Key Account & Solutions Strategy, Peter Van Beek will be the lead key account management resource for all of Semex’s European sales teams. Peter will have a hands-on role in our key account strategies and will serve as Semex’s technical expert, working closing with our sales teams to provide our clients with custom solutions.

Peter is excited to return to the AI business after managing a portfolio of calf milk replacers for Nukamel. Previous to that, he was an International Sales Manager and International Elite ... Read More...

SEMEX'S ELEVATE™ PROGRAM DELIVERS FEMALE IMMUNITY+ TEST

Five years after the introduction of Immunity+®, the revolutionary, award-winning genetic technology that was developed by Dr Bonnie Mallard at the University of Guelph, Semex is taking the next step and bringing it to clients worldwide. With the Elevate program, Semex is now offering a genomic test that ranks and selects cows based on their genetic merit along with their Immunity+ genomic test results!
Immunity+ results speak for themselves with results achieved on large commercial herds comprised of 35,000 cows and 75,000 heifers being analysed for disease reduction. It was found that Immunity+ sired animals had anywhere from 2%-20% less disease, depending on which disease was analysed. The most significant reductions in this dataset were found in the traits with the biggest economic impacts, including a 20% reduction in cow mortality among the Immunity+ sired animals. Dairy producers worldwide have seen healthier herds as a result of using Immunity+ sires, resulting in less treatment costs, less drug and antibiotic use and less time spent dealing with sick cows. The introduction of Elevate only speeds up the process.
"With Elevate and its Immunity+ genomic test, producers no longer have to guess which cows are their healthiest," says Gordon Miller, Semex Sr. Vice President, Sales & Business Development. "Instead, they're able to tailor their breeding program with both genomic information as well as Immunity+ results categorized as high, average or low health. They're able to make faster genetic progress towards a stronger, more disease resistant herd, reducing losses and drug use. Immunity+ heritability is 30%, similar to that of milk production. We're excited for herd health gains that can be made by both identifying female health and utilizing Immunity+ sires!"
Currently available in Canada, the US, Germany and the UK, Elevate and its Immunity+ genomic test supplies Semex clients with the same information as other ... Read More...

Recombinetics and Semex Form Alliance to Improve Animal Well-being

Recombinetics has formed an alliance with Semex, a Canadian-based, farmer-owned cattle genetics organization, to implement a precision breeding program that improves animal health and well-being through hornless dairy cattle genetics. The dehorning of calves is a routine procedure, designed to prevent injuries both to other animals and to handlers. This is uncomfortable for animals and is an unpleasant task for farm personnel. By using precision breeding technology, polled genetics can be reliably introduced into elite dairy lines, eliminating the need to dehorn calves. Dairy farmers prefer hornless (polled) cattle, but traditional breeding for this trait, more commonly found in certain breeds of beef cattle, is inefficient and reduces productivity. The alliance's objective is to seamlessly integrate the polled trait into high-merit dairy genetics through precision breeding. The project is being led by Tad Sonstegard, Ph.D., Chief Scientific Officer of Acceligen, Recombinetics' agriculture division. Sonstegard states, "The polled trait has been part of bovine genetics for more than 1,000 years, and it has been conventionally bred and selected for in some cattle breeds, but not in most high-merit dairy breeds.  We have proven we can safely introduce the polled trait into any breed of horned dairy cattle with complete precision. This new partnership will provide unique opportunities for dairy farmers and artificial insemination companies to introduce polled genetics without losing genetic diversity or production potential." Precision breeding uses gene editing to make small adjustments to the genome of an animal to delete, repair, or replace individual elements of DNA. In this case, the cell's natural repair function is used to replace the horned gene with a naturally occurring polled gene. The result is dairy calves that are born naturally hornless, providing a direct benefit to the animals' well-being and ... Read More...

IMMUNITY+®: THE INDUSTRY'S ONLY SOURCE FOR DISEASE RESISTANCE THAT IS PROVEN ON FARM

First offered in December 2012, Semex's exclusive Immunity+ lineup continues to expand in April 2018, offering dairymen worldwide the  sires they need to breed healthier and more profitable herds.  Proven on farm, recent research concludes that Immunity+ is the key to the future of herd health. In North America, over 30 herds comprising ~35,000 cows and ~75,000 heifers were analyzed for disease reductions (Larmer et al., 2017). It was found that Immunity+ sired animals had anywhere from 2-20% less disease (depending on which disease was analyzed). The most significant reductions in this dataset were found in the traits with the biggest economic impacts, including a 20% reduction in cow mortality among the Immunity+ sired animals. Reductions in disease incidence have also been shown in herds across Europe, South America ... Read More...

SEMEX PROMOTING FROM WITHIN

As the bovine genetics industry continues to change, Semex also continues its growth trajectory. We're focused on our people, our strategy and our genetic solutions. We believe that people are the cornerstone of our success and we're pleased to announce the following promotions from within:  Semex is pleased to announce Michael Hurst has been named Director, USA Sales & Business Development. Most recently, Michael has been the Senior Sales Manager for Semex in the US, working closely with the sales team since his return to Semex in 2016. In this business unit leadership role, Michael will report directly to Gordon Miller, Sr. Vice President, Sales & Business Development.   Concurrently, Paul Krueger has been appointed to the new position of Vice President, Global Key Account & Solutions Strategy. Key to Semex's global growth, Paul will provide leadership and direction within Semex's key growth drivers. He will work closely with Semex's Business Unit Management Team, being responsible for key account strategy and management, our global IVF strategy, Immunity+® program management as well as strategizing and managing Semex's Solutions Suite to our global clients.  "We're extremely excited to have Michael assume full management of our US Sales Team and for Paul to take on this new global role," says Gordon Miller, Sr. Vice President, Sales & Business Development. "Semex is proud to develop our leaders from within and we look forward to their continued contributions. Both gentlemen have the hands-on experience working with dairymen and our sales teams that make them ideal to deliver the industry's most innovative solutions to our clients." ... Read More...

DR. MEHDI SARGOLZAEI APPOINTED SEMEX SENIOR GENETICIST

Semex is pleased to announce that Dr. Mehdi Sargolzaei was promoted to the position of Senior Geneticist at Semex, effective January 1, 2018.   Reporting to Dr. Michael Lohuis, Semex Vice President, Research & Innovation, Dr. Sargolzaei continues working with Semex's Genetics Research Team, expanding his responsibilities to include genomics project management and platform development.     Dr. Sargolzaei is extremely familiar to the Semex family, having first joined Semex's Research & Development Team at Boviteq in June 2009 as a Research Genomicist. In January 2014, he joined Semex's Genetic Team as Research Genomicist.   "We are excited to have Dr. Sargolzaei take a leadership role in Semex's genetic and genomic programs," says Lohuis. "Mehdi brings a wealth of experience in genomic evaluations, imputation and software development that will enable Semex to provide an even greater array of products and services to the global cattle breeding industry."   An accomplished geneticist with a Ph.D. in Animal Breeding & Genetics from Niigata University in Japan, an M.Sc. in Animal Breeding & Genetics from Isfahan University of Technology, Iran, and a B.Sc. in Animal Science from Sistan & Baluchestan University, Iran, Sargolzaei's extensive career began as a Research Assistant, National Animal Science Research Institute, Karaj, Iran. He later joined the University of Guelph, Centre for Genetic Improvement of Livestock in 2006 as a Research Associate. In this position, he developed several statistical methods and software tools, including "FImpute" and "snp1101", aiming at analyzing large scale genomic data encountered in livestock populations. The driving force behind his software developments has been a keen interest in applying newer statistical methods and advanced programming techniques for analyzing big genomic data.   He has authored/coauthored 65 peer ... Read More...

Semex & Immunity+ Lineup Grows Stronger In December

Five years ago Semex answered the call of dairymen everywhere who wanted to breed more healthy cows with the launch of Immunity+, offering a genetic solution to health traits. Since then dairymen worldwide have seen firsthand the results of breeding healthier herds through the Immunity+ lineup. Five years later, real world data backs up the decades of research Semex supported at the University of Guelph in Canada under the direction of Dr. Bonnie Mallard, BSc (Agr), MSc, PhD, Professor Immunogenetics, Department of Pathobiology. "We have taken data from over 35 large commercial herds, and analyzed data from over 30,000 cows and 75,000 heifers," says Dr. Steven Larmer, Semex Dairy Solutions Coordinator. "The results have been astonishing. Reductions in every major disease have been seen, and range anywhere from 5-20% reduction in animals sired by Immunity+ sires compared to all others. Mastitis, lameness and mortality saw especially large decreases in frequency." "We hear from dairymen worldwide on a daily basis that their Immunity+ sired calves out-perform their herdmates," says Paul Krueger, Semex Vice President, US Sales & Global Marketing. "We're actively selecting sires that offer both Immunity+ and the genetic package needed. And in December, this lineup is stronger than ever." 13 Holstein sires over +2700 GTPI 24 Holstein sires over +2600 GTPI 14 Holstein sires over +800 NM$ 10 sires over 1000 DWP$ 10 sires over +3.00 PTAT 41 sires under 7% SCE 32 Jersey Immunity+ sires 12 Ayrshire Immunity+ sires Semex's lineups are growing with both proven and Genomax™ sires reigning popular and valuable worldwide: 70 over +800 NM$ 54 over +2700 GTPI 45 over 1000 DWP$ 45 over +2000 PTAM 45 over +3.00 PTAT #1 PTAT Sire 0200HO10036 OH-River-SYC ... Read More...

SEMEX'S DOORMAN AND SON DOMINATE ROYAL WINTER FAIR HOLSTEIN SHOW

The Royal Agricultural Winter Fair's Canadian National Holstein Show showed 200HO sires continuing dominance in the show ring as global superstar 0200HO06480 Val-Bisson Doorman impressively sired 32 animals that placed in the top 10 in their respective classes.   These top placing individuals included three first places, 18 in the top five as well as the Res Junior Champion and 1st Jr Yrlg, JM Valley Doorman Lexi and Hon. Mention Intermediate Champion and 2nd Jr 3 Yr Old, Trefle Chassep Doorman. Known the world over as a fantastic sire of show winners and the #2 PTAT sire at +3.67   "Doorman has proven, that he is seriously taking over the reins as the Premier Sire at major shows," says Julien Chabot, Semex Product Acquisition Specialist. "His domination was clear at the Royal, impressing with their harmonious balance of length and dairyness, combined with strength and the perfect width of frame. You add to this, their shallow, well-attached and veinatious udders with great feet & legs, and you get the complete package legends are made of. He makes the outstanding heifers that grow into special young cows that can win in the big league!"   Popular Genomax™ sire and Doorman son, 0200HO10146 Walnutlawn Solomon impressively sired six in the top 10 including the Junior Champion and 1st Summer Yearling, Kingsway Soloman Gorgeous.   Brian Carscadden, Semex Product Acquisition Specialist comments on Solomon, "Solomon's family originates from Glen Drummond and was developed by Gen-I-Beq and Misty Springs. A Doorman from a tremendous Lavanguard, he's definitely created a buzz as they begin to freshen, with shallow, well-attached udders and deep, open frames. They are very mobile and have a very correct slope from hooks to pins. There's exciting days ahead for Solomon and I would not expect his popularity to wane anytime soon!"   Adding to ... Read More...

Semex's Millionaire Sire Fever Passes Away

Semex is saddened to announce that it’s 13th Millionaire Sire, 0200HO05592 Crackholm Fever, has passed away.   Debuting as the #2 Conformation sire in August 2010, Fever quickly became a stand-out in a sea of Goldwyn sons, and was dubbed the ‘Longevity King,’ as his proof only seemed to grow stronger as he added daughters from proof round to proof round. In August 2013, he was named the #1 second crop conformation sire, and with his great health traits and exceptional fertility he quickly became an international sensation, garnering his own searchable hashtag on social media… the #feverfanclub that is still active today.   "Fever was a truly exceptional bull,” says Paul Krueger, Vice President Global Marketing. “He stood out from all other Goldwyn sons because he offered high conformation along with desirable health traits. We’re extremely proud of the success he has had on dairies worldwide. Owners tell us that their Fevers are some of their most profitable and favorite cows they have. We’re very fortunate to have a limited quantity of Fever semen available, allowing dairymen to continue using this extremely popular Millionaire Sire.” ... Read More...